We hope this email finds you well. Journal of Advanced Biotechnology and Experimental Therapeutics (JABET), an open-access journal, is pleased to announce a new Special Issue entitled "Artificial intelligence in precision healthcare: From disease diagnosis to personalized treatment". I am serving as a guest Editor for this issue.

We believe that your work would fit perfectly in the Special Issue, so we would like to offer you the opportunity to publish a paper with a 25% discount on the total APC of 396 USD if your manuscript is accepted following peer review. This discount is valid only for Submissions before 30 September 2026. To get the discount, please mention SI2026 on the cover letter.

The submission deadline is 01 December 2026, and manuscripts may be submitted immediately or at any point until 01 December 2026, as papers will be published on an ongoing basis if accepted for publication following peer review. For more information on this Special Issue and submission guidelines, please visit the following page: https://www.bsmiab.org/jabet/special-issues/2026-special-issue

JABET (ISSN 2616-4760) is an open-access, international, peer-reviewed scientific journal publishing original research, reviews, editorials, short communications, and commentaries on all aspects of biotechnology and experimental therapeutics. It is abstracted and indexed by Scopus, CrossRef, DOAJ, and many more. On average, a first decision will be provided to authors 28 days after submission, and the median publication time from acceptance to publication is 5-7 days.

We look forward to hearing from you.

Kind regards,
Guest Editors
Jia Uddin, PhD; Woosong University, South Korea
Mohammad Zavid Parvez, PhD; Torrens University, Australia
Editorial Office
Journal of Advanced Biotechnology and Experimental Therapeutics
Email: jabet.editor@bsmiab.org, or jabet.editor@gmail.com 
Follow Us: Website | Twitter | LinkedIn | Facebook |